MRK
30
5
ABT
62
5
WM
82
3
EXR
60
5
SRE
68
4
TRV
58
3
MTCH
26
-7
CTSH
65
2
COST
66
6
DFS
68
-2
SJM
21
2
SIG
49
2
PSX
42
2
WBA
47
-3
GWW
78
2
FRT
48
5
HPE
70
17
PHM
63
4
EW
27
2
RIG
58
-2
MRK
30
5
ABT
62
5
WM
82
3
EXR
60
5
SRE
68
4
TRV
58
3
MTCH
26
-7
CTSH
65
2
COST
66
6
DFS
68
-2
SJM
21
2
SIG
49
2
PSX
42
2
WBA
47
-3
GWW
78
2
FRT
48
5
HPE
70
17
PHM
63
4
EW
27
2
RIG
58
-2
Financhill
Back

Harmony Biosciences Holdings 10K Form

Buy
66

HRMY
Harmony Biosciences Holdings

Last Price:
36.05
Seasonality Move:
-3.88%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive HRMY News And Ratings

See the #1 stock for the next 7 days that we like better than HRMY

HRMY Financial Statistics

Sales & Book Value

Annual Sales: $582.02M
Cash Flow: $70.5M
Price / Cash Flow: 9.51
Annual Sales: $10.46
Price / Book: 3.45

Profitability

EPS (TTM): 2.11000
Net Income (TTM): $122.63M
Gross Margin: $460.79M
Return on Equity: 23.59%
Return on Assets: 14.52%

Harmony Biosciences Holdings Earnings Forecast

Key Harmony Biosciences Holdings Financial Ratios

  • The Gross Profit Margin over the past 6 years for HRMY is 79.17%.
  • The Selling, General & Administrative Expenses for HRMY have been equal to 33.11% of Gross Profit Margin.
  • The Research & Development expenses have been 13.07% of Revenue.
  • The Interest Expense is 18.44% of Operating Income.
  • The Net Earning history of HRMY is 22.14% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 3 years.

Harmony Biosciences Holdings Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: HRMY
Website: harmonybiosciences.com

Debt

Debt-to-Equity Ratio: 0.31
Current Ratio: 3.24
Quick Ratio: 3.05

Price-to-Earnings

Trailing P/E Ratio: 16.94
Forward P/E Ratio: 8.15

HRMY Technical Analysis vs Fundamental Analysis

Buy
66
Harmony Biosciences Holdings (HRMY) is a Buy

Is Harmony Biosciences Holdings a Buy or a Sell?